Advanced search
Search Results: 257 results for keyword "Meta".
Telix Doses First Patient in Pioneering ZOLAR Trial for Advanced Soft Tissue Sarcoma
1 ngày trước
Telix Pharmaceuticals Limited today announces that a first patient has been dosed in the Phase 1 ZOLAR[1] trial of TLX300-CDx (89Zr-olaratumab) in patients with advanced, metastatic soft tissue sarcoma (STS) at the Melbourne Theranostic Innovation Centre (MTIC) in Melbourne, Australia.
Innovent Dosed First Participant in Phase 3 Clinical Study of IBI354 for Platinum-resistant Ovarian Cancer
24-03-2025 07:00
Innovent Biologics, Inc., a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ophthalmology and other major diseases, announces that the first participant has been successfully dosed with IBI354 in a randomized, controlled, multicenter Phase 3 clinical trial, for platinum-resistant ovarian cancer with HER2 expression.
Pantheon Lab Introduces Enhanced Digital Human with Emotional Intelligence
19-03-2025 02:00
Pantheon Lab, a leader in digital human and agentic AI technologies and a proud member of the NVIDIA Inception program, today launches its latest Metahuman Interface (MHI) featuring advanced emotional intelligence.
Digital Travel Credentials Take Off, Achieving 15% Global Penetration by 2032
18-03-2025 19:03
Digital Travel Credentials are due to become part of the growing identity metasystem worldwide as the newest manifestation of digitalized identity, driven by leading identity and biometrics vendors under the aegis of enhanced passenger efficiency and bolstered security within the travel and immigration subsegments.
Social media giants pay $109 million in February taxes
17-03-2025 18:12
According to the Department of Taxation under the Ministry of Finance, foreign service providers including Google, Meta, and TikTok paid taxes worth VND2.79 trillion ($109.3 million) in February.
Moloco Commerce Media and MetaRouter Partner to Drive Privacy-First Ad Personalization at Scale
26-02-2025 03:00
Moloco, a leader in operational machine learning (ML) and performance advertising, today announced a partnership with MetaRouter, a leader in server-side tag management and pioneer in enterprise-grade data collection and integration.
Innovative Surface Treatment in the Electronics Industry
20-02-2025 18:57
Plasmatreat, a leading company in the field of surface treatment with plasma technology, developed the REDOX-Tool: an environmentally friendly, chemical-free solution for removing oxide layers from metal surfaces.
Innovent Announces Second New Drug Application of DOVBLERON was Approved by China's National Medical Products Administration
03-01-2025 07:00
Innovent Biologics, Inc., a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ophthalmology and other major diseases.
Innovent Enters into Exclusive Global License Agreement with Roche for Novel DLL3 Antibody Drug Conjugate
02-01-2025 06:30
Innovent Biologics, Inc., a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ophthalmology and other major diseases.
National Taipei University Redefines Smart Campuses with CAYIN Technology and Advantech
24-12-2024 12:23
National Taipei University has set a new benchmark in smart campus innovation by successfully implementing a cutting-edge E-Paper Timetable System.
Results Unveiled for the Phase III Study of Disitamab Vedotin in Treating HER2-Positive Advanced Breast Cancer with Liver Metastasis
13-12-2024 06:20
On the morning of December 12, 2024 (UTC-6), at the Poster Spotlight Session "Novel HER2 Therapeutics" of the 47th San Antonio Breast Cancer Symposium (SABCS), RemeGen Co. Ltd. ("RemeGen") (9995.HK, 688331.SH) presented for the first time the data from a phase III study (RC48-C006, NCT03500380) of Disitamab Vedotin (DV) in treating patients with HER2-positive advanced breast cancer with liver metastasis (BCLM).
Big Pictures and RaonMeta Join Forces to Launch Metaverse Construction Machinery Training for Learners Worldwide
06-12-2024 07:00
Big Pictures, a leading provider of virtual training solutions, is revolutionizing construction machinery education through a groundbreaking partnership with RaonMeta, an innovative Metaverse platform company.
KIWI design Black Friday & Cyber Monday: 50% OFF Meta Quest 3/3S Accessories!
22-11-2024 01:00
The biggest shopping season of the year is here! KIWI design offers incredible discounts of up to 50% on Amazon and the official website.
Australia's EQ Resources Limited takes over Tungsten Metals Group Limited
20-11-2024 09:23
EQ Resources Limited (EQR) announced on November 18 that it has bought out Tungsten Metals Group Limited (TMG).
Rokid Glasses: Where AI Meets AR, Rivaling Meta's Ray-Ban in an Exclusive Unveiling at Rokid Jungle 2024
15-11-2024 06:45
Rokid is poised to unveil its groundbreaking next-generation smart glasses, the Rokid Glasses, at the highly anticipated Rokid Jungle 2024 event, set to take place on 18 November in Hangzhou, China.
Mobile Version
